Clinical Trial Update: Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers [Phase 3]

View source ↗

Summary

This document notes the completion of a Phase 3 clinical trial evaluating fluoxetine as a smoking-cessation aid in depression-prone smokers, sponsored by the US…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Nicotine Dependence

Drugs mentioned

• Fluoxetine (Prozac) (Fluoxetine)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Depression, Smoking | Phase 3 | Status: COMPLETED